Finra expels New York-based NYPPEX for securities fraud

Finra expels New York-based NYPPEX for securities fraud
The firm's former CEO, Laurence Allen, is barred and its current CEO, Michael Schunk, is suspended.
SEP 30, 2022

The Financial Industry Regulatory Authority has expelled New York broker-dealer NYPPEX for engaging in securities fraud and barred its former CEO, Laurence Allen, for fraud and failing to respond in a timely and complete manner to Finra requests for information and documents. NYPPEX ran a private equity fund.

Finra also barred Michael Schunk, NYPPEX’s current CEO and chief compliance officer, for his failure to supervise Allen and suspended Schunk for two years for engaging in other misconduct — the maximum suspension under Finra’s sanction guidelines.

In May 2021, Finra’s enforcement department filed a nine-cause complaint against NYPPEX, Allen and Schunk alleging a pattern of misconduct that followed a temporary restraining order issued against Allen and others in December 2018 by a New York state court.

The current action came following an 11-day hearing by an extended hearing panel, which ruled in favor of the enforcement department on all nine causes of action.

The panel found that shortly after the December 2018 court order, NYPPEX and Allen started an aggressive sales campaign to raise $10 million by selling interests in NYPPEX’s parent company, NYPPEX Holdings. The panel concluded that during the campaign, NYPPEX and Allen committed securities fraud when they “intentionally or, at a minimum, recklessly” made material misstatements and omissions to prospective investors about NYPPEX Holdings’ valuation and financial condition, the New York court’s order against Allen, and the ongoing investigation by the New York Attorney General into Allen and NYPPEX-affiliated entities, among other matters.

'IN the Nasdaq' with Joel Schiffman, head of intermediary distribution in North America at Schroders

Latest News

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

Investors accuse Netcapital of inflating revenue through sham deals
Investors accuse Netcapital of inflating revenue through sham deals

Sham agreements allegedly padded revenue by 345%.

Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli
Pre-retirees are looking for flexibility, security, and guidance when it comes to retirement income: Cerulli

"Most pre-retirees are uncomfortable making key retirement income decisions without an advisor's help," said Chris Bailey of Cerulli.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor